Key statistics
On Friday, ProQR Therapeutics NV (PRQR:NAQ) closed at 2.32, 116.82% above the 52 week low of 1.07 set on Apr 09, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 2.33 |
---|---|
High | 2.42 |
Low | 2.27 |
Bid | 2.34 |
Offer | 2.50 |
Previous close | 2.36 |
Average volume | 357.84k |
---|---|
Shares outstanding | 105.21m |
Free float | 88.05m |
P/E (TTM) | -- |
Market cap | 248.30m USD |
EPS (TTM) | -0.3762 USD |
Data delayed at least 15 minutes, as of Jul 11 2025 21:00 BST.
More ▼
- ProQR Announces CTA Submission for Phase 1 Study of AX-0810 Targeting NTCP
- ProQR Announces Upcoming Scientific Presentations at ASGCT and TIDES Conferences
- ProQR Announces First Quarter 2025 Operating and Financial Results
- ProQR Announces Webcast of Presentation at the 2025 Citizens Life Sciences Conference
- ProQR Announces Annual General Meeting of Shareholders to be Held June 3, 2025
- ProQR Strengthens Leadership with Appointments of CFO and CMO to Support Next Phase of Growth
- ProQR Announces Year End 2024 Operating and Financial Results
- ProQR Therapeutics Announces $8.1 Million in New Funding from Rett Syndrome Research Trust to Expand RNA Editing Collaboration
- ProQR Appoints Peter A. Beal, PhD, as Chief ADAR Scientist
- ProQR Therapeutics to Host Virtual Analyst and Investor Event on December 11, 2024
More ▼